Professor Nina Tirnitz-Parker is the Director of the Curtin Medical Research Institute and a tenured Research Academic in the Curtin Medical School. She completed her undergraduate studies at Johannes Gutenberg-Universität in Mainz, Germany, before undertaking a PhD at the University of Western Australia.

As a translational researcher, Nina has served the Gastroenterological Society of Australia (GESA) in numerous senior leadership roles over the years, including Chair of the Research and Grants Committee, Executive Committee Member of the Australian Liver Association, and elected Board Director (2019-2020, 2021-2023, 2023-2025). She also serves as an Associate Editor for Cancer Letters and, in 2019, edited the reference book Hepatocellular Carcinoma (Codon Publications).

Nina is an alumna of the international leadership programme for women in STEMM, Homeward Bound, which culminated in an all-female expedition to Antarctica in 2019. She is passionate about mentoring the next generation of research leaders and advocates for the guiding principles of health equity and kindness in science.

Professor Leedman is Director of the Harry Perkins Institute of Medical Research, an endocrinologist, the Head of the Laboratory for Cancer Medicine, Chairman of Linear Clinical Research Ltd and co-founder of biopharmaceutical company MiReven. He completed his medical training at The University of Western Australia (UWA), specialising in endocrinology. He undertook his PhD at the Walter and Eliza Hall Institute in Melbourne and Post-doctoral Fellowship at Harvard Medical School in Boston. Professor Leedman returned to Perth in 1994 as a Senior Lecturer in Medicine at UWA, becoming a Professor of Medicine at UWA/Royal Perth Hospital in 2003, a role he holds today. His research team is developing new RNA-mediated ways to treat primary liver cancer and to overcome the all too frequent resistance to current therapies in advanced disease. He became a Fellow of the Australian Academy of Health and Medical Sciences in 2016.

Dr Wallace is a consultant hepatologist and gastroenterologist who graduated from the University of Western Australia and underwent specialist training in gastroenterology and hepatology at Sir Charles Gairdner Hospital and Royal Perth Hospital.

After completing his specialist training, he undertook a Post-doctoral Fellowship at the Mount Sinai School of Medicine in New York City, where his research areas included hepatocellular carcinoma and the treatment of liver fibrosis, he completed his PhD at UWA in the area of HCC.

Dr Winteringham is a cancer biologist and leads the Translational Cancer Research Program at the Perkins. She has over twenty-five years’ experience in discovery cancer research, focused on understanding the biochemistry and molecular genetics of novel cancer genes. Dr Winteringham is the CI for the Perkins Cancer Biobank which  includes both biospecimens and laboratory generated research data. Integrating these data with extensive clinical data will support a precision medicine approach to cancer treatment.